ILSE

Institute for Life Science Entrepreneurship

NJBiz Article on Antibiotic Resistance

By

The recent NJBiz article on Research on Antibiotic Resistance published in December 2018, features Dr. Keith Bostian, CEO of ILSE. Dr. Bostian discusses the research that is happening on the field at ILSE and  Kean University. The full article can be viewed here

ILSE Awarded NJEDA Planning Grant

By

The Institute for Life Science Entrepreneurship (ILSE) has been awarded a $100,000 planning grant in partnership with Union Township to expand its outreach to life science entrepreneurs and its university programs. A Union Township proposal to expand ILSE Life Science Incubator received one of nine New Jersey Economic Development Authority (NJEDA) Innovation Challenge awards. The […]

Virtual Roundtable: Challenges in Harmonization for Enabling Technologies Consortium on Translational Research in the Microbiome

By

Over the past decade, the human microbiome as an avenue for new drug discovery and development has gained significant attention from academics, industry professionals, funding agencies and investors. However, much of the data to date has only provided correlative evidence of clinical applications, leaving many technical challenges and unknowns. To realize the potential of this […]

2018 Regional Academic Drug Discovery Conference

By

The New Jersery Academic Drug Discovery Consortium is hosting its 2nd annual meeting at Rutgers University this year. The conference is taking place on Thursday, November 15 at the Ernest Mario School of Pharmacy. When Thursday, November 15, 2018 from 8:00 AM to 4:00 PM EST Add to Calendar Where Rutgers University Ernest Mario School […]

ILSE releases white paper on laboratory and innovation space in NJ

By

Institute for Life Science Entrepreneurship (ILSE) on July 18, 2018 released its white paper on innovation spaces.  Entitled “Recent Advances in Laboratory and Innovation Space in New Jersey“, the paper includes profiles of major biopharma incubators and innovation spaces in New Jersey and perspectives from leaders of successful industrial and academic incubators.  The white paper […]

ILSE Launches new Company Micorgenomx, Inc

By

ILSE has formed a new microbiology and genomics company, Microgenomx, Inc., to develop cutting edge new technology and to provide services to antibiotic, microbiome and other microbiology-related companies. We are running an introductory offer for mutational analysis studies, integrating microbiology, whole genome sequencing and bioinformatics analysis, at very attractive pricing, for a few companies. Bob […]

Prokaryotics an ILSE Startup Announces Licensing Agreement with Merck

By

Prokaryotics Announces Licensing Agreement with Merck for Novel Investigational Antibiotic Candidates   Union, NJ – January 25, 2018 — Prokaryotics, Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into a licensing agreement with Merck, known as MSD outside the United States and […]

Main Menu